Vanda Pharmaceuticals (VNDA) Assets (2010 - 2026)

Vanda Pharmaceuticals' Assets history runs 17 years deep, the most recent figure standing at $433.5 million for Q1 2026.

• In Q1 2026, Assets fell 31.4% year-over-year to $433.5 million; the TTM figure through Mar 2026 stood at $433.5 million (down 31.4% YoY), while the FY2025 annual figure was $488.9 million, down 25.49% from the prior year.
• Assets came in at $433.5 million for Q1 2026 at Vanda Pharmaceuticals, down from $488.9 million in the prior quarter.
• In the past five years, Assets ranged from a high of $656.2 million in Q4 2024 to a low of $433.5 million in Q1 2026.
• A 5-year average of $613.6 million and a median of $634.2 million in 2022 frame the typical range for Assets.
• Across the five-year window, Assets rose 11.11% in 2022 and tumbled 31.4% in 2026, its largest moves.
• Vanda Pharmaceuticals' Assets stood at $634.2 million in 2022, then climbed by 2.24% to $648.4 million in 2023, then increased by 1.2% to $656.2 million in 2024, then decreased by 25.49% to $488.9 million in 2025, then dropped by 11.34% to $433.5 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $433.5 million, $488.9 million, and $601.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison